Private Label Supplement Manufacturer, Valimenta Labs Introduces CELLg8™ Technology
CELLg8™ Technology Uses Naturally-Occurring Lipids to Increase Bioavailability of Active Nutrients in Supplements
WELLINGTON, Colo., Jan. 27, 2019 /PRNewswire-PRWeb/ -- Colorado-based private label supplement manufacturer, Valimenta Labs is proud to introduce its proprietary, patent pending CELLg8TM technology to the supplement industry that will be released in CELLg8™ liquid February.
"Scientific studies have shown that many of the vitamins, nutrients and active compounds present in mass-produced supplements are destroyed in the gut, before ever being bioavailable to the small intestines. In some cases, most or all of the active nutrients have been reported to be lost during digestion," said Dr. Emek Blair, Founder and Chief Scientist at Valimenta Labs.
The CELLg8TM technology developed by Dr. Blair and now offered by Valimenta Labs combats the issue of reduced bioavailability by using naturally-occurring lipids as a sheath to preserve actives during digestion.
"Our Cellg8TM technology offers the most advanced evolution of liposome technology available. Leveraging our years of experience in designing and developing delivery solutions along with our clinical studies and vast understanding of liposomes, we have been able to develop technology that is proven to improve absorption of certain actives more than any other delivery solution in the marketplace," said Dr. Blair.
Formulas using this technology start shipping February, 2019.
Testing the CELLg8TM technology with green tea extract research showed that the active compounds in green tea were detected in significant amounts in whole blood when using the CELLg8TM technology in a powder form, however, no detectable levels were found in the blood for plain raw green tea actives consumed without the CELLg8™ delivery technology.
"The stomach will vaporize more vitamins than it absorbs and we've found a way to safely increase bioavailability without reducing quality or taste. Our CELLg8TM lipid delivery technology is clean, safe and perfected as a scalable production process," said Blair. "Valimenta, again, is ready to build the next generation of supplement products."
In 2019 we announced our Cellg8 technology, the most modern evolution of liposome technology available. We leveraged the years of experience and designing and developing delivery solutions with our experience and clinical studies to bring a technology that has now shown to improve absorption of certain actives more than any other delivery solution that we could find in the marketplace.
"With this new delivery system, we have effectively reached the limit of absorption through ingestion." Look for the CELLg8™ logo on the bottle to make sure you are getting the real thing.
About Dr. Emek Blair
In early 2015, Dr. Blair founded Valimenta to provide B2B private label manufacturing for custom liposomal products, vitamin supplements, herbal extracts and energy/nutrition drinks. Valimenta uses the proprietary method developed by Dr. Blair which does not require high pressures, high temperatures or toxic synthetic chemicals.
Dr. Blair has formulated upwards of 100 unique liposomal formulas that have successfully been brought to market by some of the largest brands in the world. Several of Dr. Blair's formulas have been internationally recognized and awarded by the science and supplement industries. He is the inventor and formulator behind some of the most well known brands in this space.
Dr. Blair continues to perform clinical trials with various high-impact medical doctors around the world; this research shows how natural products, when properly delivered, are critical to maximizing health.
For more information about Dr. Emek Blair, visit dremekblair.com.
About Valimenta Labs
Valimenta Labs is a direct manufacturer of advanced liposomal vitamin products and innovative vitamin packaging solutions.
Headquartered out of its state-of-the-art cGMP Certified lab in Colorado, Valimenta is the only supplement manufacturer to be specifically certified to produce liposome supplements. In 2012, Valimenta partnered with a team at the Department of Health and Exercise Science at Colorado State University to perform clinical studies which prove the effectiveness of organically wrapping vitamins, nutrients and active compounds in molecules of fat through our fourth generation of liposomal manufacturing. Since then, we have vastly improved into the next level of delivery systems with CELLg8™ with a clinical collaboration in Boulder CO.
For more information about Valimenta Labs, visit valimenta.com.
SOURCE Valimenta Labs
Share this article